Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > SR17018 for Sale > SR17018 raw powder CAS 2134602-45-0 High Purity
SR17018 raw powder CAS 2134602-45-0 High Purity buy - large image1
SR17018 raw powder CAS 2134602-45-0 High Purity buy - image1

SR17018 raw powder CAS 2134602-45-0 High Purity

223 Inquiries

Unit Price: Get Latest Price
CAS No.:

2134602-45-0

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shanghai

Brand:

Huarong Pharm

Packaging:

Aluminum foil bag

Price valid (until):

2026-04-05

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

SR17018,Retatrutide,Tirzepatide,Semaglutide,SLU-PP-332,Atorvastatin tert-Butyl Ester (L2)

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Pls input...

    Items Specifications
    Appearance
    Off-white to yellowish powder
    NMR
    Consistent with reference spectrum
    Purity (HPLC)
    ≥98% 

    Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 1 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 2 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 3 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 4 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 5 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 5 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 6 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 7 Shop SR17018 raw powder CAS 2134602-45-0 High Purity-Detailed Image 8

    Basic Info
    Product Name:

    SR17018

    Other Name:

    SR17018;CS-2685;SR1 7018;SR-17018;SR17018;2H-Benzimidazol-2-one, 5,6-dichloro-1-[1-[(4-chlorophenyl)methyl]-4-piperidinyl]-1,3-dihydro-;SR 17018,SR17018,Opioid Receptor,inhibit,SR-17018,Inhibitor;SR-17018 SR17018;5,6-dichloro-1-{1-[(4-chlorophenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one;SR17018, 10 mM in DMSO

    CAS No.:

    2134602-45-0

    Molecular Formula:

    C19H18Cl3N3O

    InChIKeys:

    LAGUDYUGRSQDKS-UHFFFAOYSA-N

    Molecular Weight:

    410.72

    Exact Mass:

    409.051545

    EC Number:

    218-362-5

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.428±0.06 g/cm3(Predicted)

    PKA:

    10.03±0.30(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    SR17018,Retatrutide,Tirzepatide,Semaglutide,SLU-PP-332,Atorvastatin tert-Butyl Ester (L2)

    Location:

    Room1101, Hakim International Building, Gongshu District, Hangzhou, Zhejiang Province, China.

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2018

    Company Certificates
    • Hangzhou Huarong Pharm Co., Limited.Drug Manufacturing Certificate Drug Manufacturing Certificate
    • Hangzhou Huarong Pharm Co., Limited.GMP Certificate GMP Certificate

              Hangzhou Huarong Pharm Co., Ltd. established since 2009 , has been always focusing on supplying products and services to our clients in the field of pharmaceutical and chemical. We have built platforms for the research, development and manufacturing of Building Blocks, Reference Compounds & Impurities, Photoresist & PI Monomers,  APIs & Intermediates,  Biosimilar, and FDF. To maintain a high innovation efficiency, the company has continuously increased the investment on R&D facilities and state-of-the-art equipment in the past several years, including the establishment of kilogram GMP conditions plants and R&D centers.

               

              We adhere to our vision, our mission, and our value, keeping abreast of the current trend and state-of-the-art science and technologies of the global biopharmaceutical industry to serve our clients to the utmost satisfaction. Our existing advantages have led to our in-depth services for the R&D of drug discovery.

               

              At present, we have successfully delivered innovative R&D products and services to more than 3,000 partners across the world. Our goal is to become a world-class leading company to support life science innovation and manufacturing.

  • Inquiry History
    223 Inquiries
    Country Product Purchase Quantity Date Posted
    Ireland

    SR17018

    50 MG Oct 19, 2026
    United States

    SR17018

    10 G Oct 18, 2026
    Canada

    SR17018

    20 MG Oct 14, 2026
    United States

    SR17018

    1 KG Oct 14, 2026
    United States

    SR17018

    7.5 G Oct 14, 2026
    Sweden

    SR17018

    10 MG Oct 11, 2026
    United States

    Sr 17018

    50 G Oct 10, 2026
    China

    SR17018

    10 G Oct 9, 2026
    United States

    SR17018

    5 G Oct 9, 2026
    Canada

    SR17018

    28  Oct 9, 2026
    United States

    SR17018

    25 G Oct 6, 2026
    United Kingdom

    SR17018

    10 G Oct 5, 2026
    Vietnam

    SR17018

    20 PCS Oct 4, 2026
    United Kingdom

    SR17018

    100 G Sep 30, 2026
    Canada

    SR-17018

    20 MG Sep 28, 2026
    United States

    Sr17018

    50 MG Sep 28, 2026
    United States

    SR17018

    15 MG Sep 28, 2026
    United States

    SR17018

    1 G Sep 23, 2026
    China

    SR17018

    1 G Sep 20, 2026
    United States

    SR17018

    2 G Sep 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.